Search results
Author(s):
Muthiah Vaduganathan
Added:
7 months ago
ESC Congress 2025 - Dr Muthiah Vaduganathan (Brigham and Women’s Hospital, Boston, US) joins us to discuss findings from a trial investigating the lifetime benefits of combination therapy for patients with HFpEF by looking at individual level data from DELIVER, FINEARTS-HF and PARAGON-HF trials.Interview Questions:1. What is the reasoning behind the trial?2. What was the study design and patient…
View more
Pharmacological Therapy of HFrEF in 2025
Author(s):
Massimo Mapelli
,
Filippo Maria Rubbo
,
Simona Costantino
,
et al
Added:
8 months ago
Review Article
Author(s):
Mirvat Alasnag
,
Khaled Al-Shaibi
Added:
1 year ago
ESC Congress 24 – Day 1 of the ESC Congress 2024 was filled with excitement as new clinical practice guidelines were unveiled, along with several highly anticipated Hot Line trials.Interventional experts Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (King Fahd Armed Forces Hospital, SA) are concluding the first day by providing practical summaries of the key guidelines and offering critical insights…
View more
Author(s):
Michelle Kittleson
Added:
7 months ago
ESC Congress 2025 - In this video, Dr Michelle Kittleson (Cedars-Sinai Heart Institute, US) outlines the hot-line data from the congress that are expected to have an impact on clinical practice in the heart failure space.Trials covered in detail include:REBOOT-CNIC: Beta-Blockers after Myocardial Infarction without Reduced Ejection FractionBETAMI-DANBLOCK: Beta-Blockers after Myocardial…
View more
Effects of GLP-1 Receptor Agonists in Heart Failure Patients
Author(s):
Anastasia Shchendrygina
,
Amina Rakisheva
,
Ilya Giverts
,
et al
Added:
1 year ago
Review Article
Author(s):
Nicolas Girerd
Added:
10 months ago
ESC HF 25 - Outcomes from a study investigating liver stiffness measurement as a non-invasive method to assess central venous pressure showed immediate results at bedside obtained in >4 minutes, with the procedure easily performed by a trained nurse.Prof Nicolas Girerd (University Hospital of Nancy, Nancy, FR) discusses a pilot validation study investigating liver stiffness as a non-invasive…
View more
DanGer Shock RCT: A Decade of Data
Author(s):
Andreas Goetzenich, Jacob E Møller, Vasileios Panoulas ,et al
Start date:
Dec 02, 2025
Broadcast
Author(s):
Ankeet Bhatt
Added:
10 months ago
ESC HF 25 - Secondary analysis of the FINEARTS-HF study shows finerenone treatment favourably influenced the risk of early heart failure readmission.Dr Ankeet Bhatt (Kaiser Permanante San Francisco Medical Center, San Francisco, US) discusses findings from the prespecified secondary analysis of the FINEARTS-HF trial (NCT04435626; Bayer). The placebo-controlled primary analysis investigated the…
View more
Author(s):
Gianluigi Savarese
Added:
1 year ago
Prof Gianluigi Savarese presents a second case study of a HFrEF patient with worsening heart failure symptoms in the outpatient clinic. The patient is already prescribed GDMT and a loop diuretic, Professor Savarese asks, ‘what are the next steps in managing this patient?’.Watch the second case by Gianluigi Savarese on Worsening Heart Failure – Inpatient Setting and a case from Javed Butler who…
View more
Author(s):
Ahmad Masri
,
Added:
1 year ago
Recorded during HFA 2024, Dr Caroline Coats, Glasgow University, UK, and Dr Ahmad Masri, Oregon Health and Science University, US, collaborate to explore the pivotal advancements in managing hypertrophic cardiomyopathy unveiled at the conference.This programme is thoughtfully divided into four chapters, facilitating a smooth journey through the latest HCM trial data, including a comprehensive…
View more